Rxo Current Ratio Growth & History (RXO)

Rxo's current ratio was 1.27 for fiscal 2025.

View full Rxo company overview

Rxo annual current ratio history

Rxo annual current ratio

Fiscal yearPeriod endedCurrent ratioChangeGrowth
20252025-12-311.270.01+0.92%
20242024-12-311.260.09+7.72%
20232023-12-311.17−0.08−6.65%
20222022-12-311.25−0.08−5.79%
20212021-12-311.33

Rxo current ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, Rxo's current ratio decreased from 1.33 to 1.27, a change of −0.06. The latest reported quarter, Q2 2026, shows 1.27.

About the metric

What the current ratio means

The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.

Calculation and source

How the current ratio is calculated

TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Rxo source filings ↗

Community posts

It’s quiet here.

No posts about RXO yet. Start the conversation.

Write the first post